Oral and Gut Microbiota Changes During Long-term Fasting in Humans

NCT ID: NCT05449249

Last Updated: 2023-01-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-09-01

Study Completion Date

2023-01-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this longitudinal trial is to investigate the effects of a 10±3-day fasting period in 30 subjects. Changes in the oral and gut microbiota, halitosis, as well as inflammatory and antioxidative parameters and biomarkers of sulfur metabolism will be analysed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Fasting has been linked with changes in gut microbiota as part of the physiological adaptation. Furthermore, associations have been described between oral disease and nutrition (diet rich in carbohydrates). The aim of the present longitudinal clinical study is to explore the effect of a 10±3-day fasting period on the oral and gut microbiota. 30 systemically healthy subjects attending the Buchinger Wilhelmi Clinics for fasting, will participate. Changes in oral microbiota will be assessed in plaque and saliva samples and a number of inflammatory markers will be analyzed in Gingival Crevicular fluid (GCF) and blood obtained before, during and after the fasting period. The changes in the oral microbiota will be associated to the composition of the gut microbiota. Changes in periodontal parameters and halitosis related to the fasting period will be further evaluated. Given the known association between sulfur metabolism and the redox status, parameters from the antioxidant status and oxidative damages will also be assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

single-arm, prospective, monocentric, interventional study
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Long-term fasting

Long-term fasting according to the Buchinger Wilhelmi fasting program.

Group Type EXPERIMENTAL

Long-term fasting

Intervention Type PROCEDURE

The participants will undergo a fasting program that includes the daily intake of 250 kcal under medical supervision.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Long-term fasting

The participants will undergo a fasting program that includes the daily intake of 250 kcal under medical supervision.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Both subjects with periodontitis and healthy periodontium will be included.
* Signed informed consent

Exclusion Criteria

* Not able to sign the informed consent
* diagnosticated with cachexia, anorexia, nervosa, advanced kidney, liver or cerebrovascular insufficiency
* Smoking
* the intake of antibiotics within the last 8 weeks, as well as the intake of probiotics within the last 4 weeks
* periodontal treatment in the last 6 months
* chronic manifest psychical and psychiatric diseases
* participation in another study
* pregnancy or breastfeeding
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Buchinger Wilhelmi Clinic

UNKNOWN

Sponsor Role collaborator

University of Geneva, Switzerland

OTHER

Sponsor Role collaborator

King's College London

OTHER

Sponsor Role collaborator

ETH Zurich (Switzerland)

OTHER

Sponsor Role collaborator

Buchinger Wilhelmi Development & Holding GmbH

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Françoise Wilhelmi de Toledo

Scientific Director; Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Françoise Wilhelmi de Toledo, MD

Role: PRINCIPAL_INVESTIGATOR

Buchinger Wilhelmi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Buchinger Wilhelmi clinic

Überlingen, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BuWi_OralFast_2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Outcomes of Periodontal Regenerative Treatment
NCT04971174 ENROLLING_BY_INVITATION